Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
20 Dec 2024
Global Consensus Forms on Low-Dose Oral Minoxidil
An international expert panel of 43 dermatologists has established an expert consensus on the off-label use of low-dose oral minoxidil (LDOM) for treating hair loss.
19 Dec 2024
Breakthroughs in IgG4-Related Autoimmune Neuropathies
A recently published review article has shed light on significant breakthroughs in the understanding and treatment of IgG4-mediated autoimmune diseases, particularly in the realm of autoimmune neuropathies.
19 Dec 2024
Functional Outcomes After Respiratory Failure Explored
Respiratory failure impacts millions annually in the U.S., leaving many survivors with lasting physical, cognitive, and quality-of-life impairments.
19 Dec 2024
Omega-3 Diet Reduces Prostate Cancer Progression
A recent Phase II clinical trial has revealed promising results for men with low-grade prostate cancer on active surveillance (AS).
18 Dec 2024
VISIBLE Study Drives Diversity in Psoriasis Research
In an effort to improve psoriasis research, the VISIBLE clinical trial has made significant strides in diversity, enrolling participants with skin of color (SoC) at an accelerated rate.
18 Dec 2024
Dynamic Model Improves Migrant Tuberculosis Detection
Tuberculosis (TB) remains a persistent health concern among migrants to low-TB-incidence countries, including Canada.
18 Dec 2024
Estrogen-Progesterone Therapy Linked to Autoimmune Risks
A recent study exploring the impact of estrogen and progesterone analog supplementation on autoimmune conditions reveals a concerning association with several diseases.
17 Dec 2024
AI Model Predicts Outcomes for Patients with Breast Cancer on CDK4/6 Inhibitors: SABCS 2024
A new AI-powered model predicts outcomes for breast cancer patients on CDK4/6 inhibitors, offering precise insights into treatment response and enabling personalized care.
17 Dec 2024
Predictors of Psoriatic Arthritis in Juvenile Arthritis
Insights into predicting psoriatic arthritis (PsA) in juvenile idiopathic arthritis (JIA) patients, 18 years after their initial diagnosis, were shared in a recent study.
17 Dec 2024
Burn Patients Face Pneumonia Risk Surge
A newly published study highlights a critical connection between inhalation injury severity and the risk of developing nosocomial pneumonia (NP) in burn patients.
←
1
2
3
…
57
58
59
60
61
62
63
…
98
99
100
→
We’ve noticed you’re accessing
from
North/South America.
View
View